CIBC analyst issues OUTPERFORM recommendation for PBA on July 3, 2026 03:14PM ET. The previous analyst recommendation was Outperform.PBA was trading at $46.44 at issue of the analyst recommendation.The overall...
BMO Capital analyst issues MARKET PERFORM recommendation for PBA on July 3, 2026 11:11AM ET. The previous analyst recommendation was Market Perform.PBA was trading at $46.44 at issue of the...
Raymond James analyst issues OUTPERFORM recommendation for AEGXF on July 3, 2026 11:18AM ET. The previous analyst recommendation was Outperform.AEGXF was trading at $34.84 at issue of the analyst recommendation.The...
Barclays analyst issues OVERWEIGHT recommendation for AALBF on July 3, 2026 10:09AM ET. The previous analyst recommendation was Overweight.AALBF was trading at $43.36 at issue of the analyst recommendation.The overall...
Barclays analyst issues OVERWEIGHT recommendation for RATIY on July 3, 2026 10:16AM ET. The previous analyst recommendation was Overweight.RATIY was trading at $38.6 at issue of the analyst recommendation.Historical Analyst...
Barclays analyst issues OVERWEIGHT recommendation for PRYMY on July 3, 2026 10:15AM ET. The previous analyst recommendation was Overweight.PRYMY was trading at $81.19 at issue of the analyst recommendation.The overall...
Barclays analyst issues OVERWEIGHT recommendation for JRONY on July 3, 2026 10:12AM ET. The previous analyst recommendation was Overweight.JRONY was trading at $38.36 at issue of the analyst recommendation.The overall...
Pareto analyst issues HOLD recommendation for GJNSY on July 3, 2026 09:58AM ET. The previous analyst recommendation was Buy.GJNSY was trading at $27.04 at issue of the analyst recommendation.The overall...
Citigroup analyst issues NEUTRAL recommendation for GJNSY on July 3, 2026 10:19AM ET. The previous analyst recommendation was Neutral.GJNSY was trading at $27.04 at issue of the analyst recommendation.The overall...
Barclays analyst issues OVERWEIGHT recommendation for BIOVF on July 3, 2026 10:17AM ET. The previous analyst recommendation was Overweight.BIOVF was trading at $48 at issue of the analyst recommendation.The overall...
